Ultragenyx Pharmaceutical (United States)
- World rank, 2022–2025
- #23,258 of 28,054 · #29,058 all time
- Rank in United States
- #3,481 of 4,192
- Research works
- 149 ▲ 395% vs 2013–17
- Citations
- 3.3k 22.3 per fractional work
- Top-10% rate
- 16.3% record average 16.5%
- Open access
- 61% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.3×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 7.3×
- Nursing 4.4×
- Medicine 2.5×
- Chemistry 1.1×
- Veterinary 1.0×
- Immunology and Microbiology 0.7×
- Economics, Econometrics and Finance 0.7×
- Agricultural and Biological Sciences 0.4×
- Health Professions 0.4×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Neuroscience 0.2×
- Physics and Astronomy 0.1×
- Decision Sciences 0.1×
- Mathematics 0.1×
- Computer Science 0.0×
- Engineering 0.0×
- Arts and Humanities 0.0×
- Social Sciences 0.0×
- Environmental Science 0.0×
- Psychology 0.0×
Which keywords describe research at Ultragenyx Pharmaceutical (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Metabolic Disorders, Genetic Mutations, Newborn Screening, Metabolism, Biochemical Genetics, Mitochondrial Function, Epilepsy and Neurodegeneration.
- Cell Culture
- Chronic Kidney Disease
- Mitochondrial Dysfunction
- Ketogenic Diet
- Viral Vectors
- AAV
- Fragile X Syndrome
- Folate
- Cognitive Impairment
- Neuroimaging
- Lysosomal Storage Disorders
- Enzyme Replacement Therapy
- Oxidative Stress
- Ehlers-Danlos Syndrome
- Inflammation
- Myoclonic Disorders
- Neurodegeneration
- Mitochondrial Function
- Metabolism
- Genetic Mutations
- Metabolic Disorders
- Newborn Screening
- Biochemical Genetics
- Epilepsy
- Glycogen
- Neurological Disorders
- Parkinson's Disease
- Marfan Syndrome
- Metabolic Syndrome
- Gaucher Disease
- Cardiovascular Disease
- Vitamin B12
- Gene Therapy
- Homocysteine
- Rett Syndrome
- Glycosylation
- Weight Loss
- Low-Carbohydrate Diet
- Basal Ganglia
- Antisense Oligonucleotides
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Metabolic Disorders8▲ 96×4 topics
- Genetic Mutations8▲ 25×4 topics
- Newborn Screening7▲ 191×2 topics
- Metabolism7▲ 20×8 topics
- Biochemical Genetics7▲ 284×1 topic
- Mitochondrial Function7▲ 106×1 topic
- Epilepsy6▲ 84×2 topics
- Neurodegeneration6▲ 27×4 topics
- Glycogen5▲ 706×1 topic
- Myoclonic Disorders5▲ 706×1 topic
- Neurological Disorders5▲ 12×9 topics
- Inflammation4▲ 2.5×15 topics
- Parkinson's Disease3▲ 20×2 topics
- Ehlers-Danlos Syndrome3▲ 225×1 topic
- Marfan Syndrome3▲ 225×1 topic
- Oxidative Stress3▲ 2.9×6 topics
- Metabolic Syndrome3▲ 4.8×6 topics
- Enzyme Replacement Therapy3▲ 210×2 topics
- Gaucher Disease3▲ 248×1 topic
- Lysosomal Storage Disorders3▲ 248×1 topic
- Cardiovascular Disease2▲ 3.3×5 topics
- Neuroimaging2▲ 13×5 topics
- Vitamin B122▲ 97×2 topics
- Cognitive Impairment2▲ 13×2 topics
- Gene Therapy2▲ 17×3 topics
- Folate2▲ 112×1 topic
- Homocysteine2▲ 112×1 topic
- Fragile X Syndrome2▲ 97×1 topic
- Rett Syndrome2▲ 97×1 topic
- AAV2▲ 65×1 topic
- Glycosylation2▲ 23×2 topics
- Viral Vectors2▲ 65×1 topic
- Weight Loss2▲ 16×2 topics
- Ketogenic Diet2▲ 26×1 topic
- Low-Carbohydrate Diet2▲ 29×1 topic
- Mitochondrial Dysfunction2▲ 8.1×3 topics
- Basal Ganglia2▲ 40×2 topics
- Chronic Kidney Disease2▲ 9.3×3 topics
- Antisense Oligonucleotides1▲ 49×2 topics
- Cell Culture1▲ 19×2 topics
Which research topics does Ultragenyx Pharmaceutical (United States) publish most on?
By volume in 2022–2025: Metabolism and Genetic Disorders, Glycogen Storage Diseases and Myoclonus, Connective tissue disorders research and Lysosomal Storage Disorders Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Metabolism and Genetic Disorders Clinical Biochemistry 7 works
- 2 Glycogen Storage Diseases and Myoclonus Rheumatology 5 works
- 3 Connective tissue disorders research Genetics 3 works
- 4 Lysosomal Storage Disorders Research Physiology 3 works
- 5 Folate and B Vitamins Research Rheumatology 2 works
- 6 Genetics and Neurodevelopmental Disorders Genetics 2 works
- 7 Virus-based gene therapy research Genetics 2 works
- 8 Diet and metabolism studies Physiology 2 works
- 9 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
- 10 Neurogenetic and Muscular Disorders Research Genetics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ultragenyx Pharmaceutical (United States)'s research output changed?
Output in 2018–2022 was 395% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Novato
- Buck Institute for Research on Aging
- Marin Community Foundation
- QT Ultrasound (United States)
- Cytograft Tissue Engineering (United States)
- XCell Science (United States)
- Pacific Breast Pathology
- Halleck Creek Ranch
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.